Search This Blog

Thursday, November 7, 2019

Progenics Pharmaceuticals EPS beats by $0.04, misses on revenue

Progenics Pharmaceuticals (NASDAQ:PGNX): Q3 GAAP EPS of -$0.22 beats by $0.04.
Revenue of $5.61M (+5.5% Y/Y) misses by $1.8M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)